Bio3 Research s.r.l. is a private biopharmaceutical company based in Milan, Italy, with a USA subsidiary, Bio3 Research Inc., based in Hayward/CA.

Bio3 Research develops new proprietary compounds up to IND stage with potential in cardiovascular field. The company is focused in the area of cardiovascular disorders related to HMGB1 (High Mobility Group Box 1) over-expression.

The HMGB1 protein and its fragments are investigated also in Connective Tissue Regeneration (wound healing, cartilage repair, bone matrix regeneration, burns, bed sorees etc).
Other Bio3 Research fields of interest are renal and skin diseases.

Bio3 Research collaborates with biopharmaceutical companies, Academy, individual scientists, to identify commercially promising innovations to patent and develop them for commercial fruition in the pharmaceutical marketplace.

Bio3's activity takes also the form of license agreements under which the use of its patents and preclinical packages are granted to third parties. 

Bio3 Research S.r.l. (Milano – Italy), is pleased to announce the official opening of a Californian subsidiary, located in Hayward…

You may also notice that we have a new website. This site was built by a company based in the UK called Sinful Design. They can be found at;

www.sinfuldesign.com